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1. Introduction
Vagal nerve stimulation (VNS) has been used clinically 
for many years for the treatment of intractable epilepsy [1]. 
However, it is becoming increasingly clear that VNS offers 
potential therapeutic benefit in a number of conditions. One 
such condition is obesity, where pre-clinical and clinical studies 
have shown VNS produces moderate weight loss [2–5]. In the 
USA, the Federal Drug Administration (FDA) has recently 
approved the use of VNS for the treatment of obesity.
The role of the vagus nerve in promoting weight loss is 
well documented. Signals which terminate feeding such as 
cholecystokinin (CCK) and gastric distension, mediate their 
effects through interacting with the vagus nerve [6–8], which 
in turn activates brainstem areas associated with satiety [9]. 
Sensitivity of the vagus nerve to these satiety signals is reduced 
in obesity [10] and is believed to be enhanced by VNS [11].
Currently the main limitation with VNS devices (and 
indeed most brain–technology interfaces), is lack of physi-
ological feedback. Integration of physiological feedback to 
control stimulation is generally associated with improved ther-
apeutic efficacy [12, 13]. Recording changes in the activity of 
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Abstract
Objective. Vagal nerve stimulation (VNS) has shown potential benefits for obesity treatment; 
however, current devices lack physiological feedback, which limit their efficacy. Changes in 
extracellular pH (pHe) have shown to be correlated with neural activity, but have traditionally 
been measured with glass microelectrodes, which limit their in vivo applicability. Approach. 
Iridium oxide has previously been shown to be sensitive to fluctuations in pH and is 
biocompatible. Iridium oxide microelectrodes were inserted into the subdiaphragmatic 
vagus nerve of anaesthetised rats. Introduction of the gut hormone cholecystokinin (CCK) or 
distension of the stomach was used to elicit vagal nerve activity. Main results. Iridium oxide 
microelectrodes have sufficient pH sensitivity to readily detect changes in pHe associated with 
both CCK and gastric distension. Furthermore, a custom-made Matlab script was able to use 
these changes in pHe to automatically trigger an implanted VNS device. Significance. This is 
the first study to show pHe changes in peripheral nerves in vivo. In addition, the demonstration 
that iridium oxide microelectrodes are sufficiently pH sensitive as to measure changes in 
pHe associated with physiological stimuli means they have the potential to be integrated into 
closed-loop neurostimulating devices.
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the vagus nerve associated with satiety signalling, and stimu-
lating it in response to them, may augment the normal physi-
ological signalling of the vagus and increase the efficacy of 
VNS. However recording such changes remains problematic.
Recording changes in electrical activity of the vagus nerve 
is one such method by which physiological feedback can be 
incorporated into VNS devices, however electrical record-
ings from peripheral nerves tend to be in the µV range [14], 
meaning they are hampered by low signal to noise ratio (SNR). 
In order to compensate for this, individual axons either have to 
be dissected out of the nerve [15], or the whole nerve removed 
for ex vivo recording [16]. Both methods severely limit the 
amount of in vivo functionality that can be deciphered. It is 
therefore clear that novel technologies for the detection of 
changes in neural activity in vivo are required for a chroni-
cally implanted device.
Previous studies have demonstrated that neural activity 
correlates with changes in extracellular pH (pHe) [17–19]. 
In the ex vivo vagus nerve, electrical stimulation results in 
alkaline pHe shifts of around 0.02 pH units and acid shifts 
of around 0.05 pH units [18]. Furthermore, in in vitro central 
nervous tissue preparations, depolarisation of neuronal mem-
branes results in pHe changes in both the acidic and alkaline 
direction [20]. Since pHe changes are recorded directly from 
within target tissues, they lack interference from distal tissues, 
providing greater SNR than traditional electrical recordings. 
However, previous studies examining pHe changes associated 
with neural activity have significant limitations, in that they 
have exclusively been performed either in vitro or ex vivo, 
and by utilising glass micropipettes to record pHe changes. 
Due to their fragility and lack of biocompatibility, the use of 
glass microelectrodes remains unsuitable for incorporation 
into implantable closed-loop devices. Recent advances in 
chemical sensing technology and materials have enabled new, 
stable methods for ionic sensing, especially with pH sensing 
(for review see [21]). Iridium oxide (IrOx) has previously been 
shown to have good pH sensing properties [22] and recently, 
we described a method for measuring pH in biological tissue 
using electrodeposited IrOx [23, 24]. An IrOx microwire has the 
advantage of being rigid, thus allowing easy penetration of the 
nerve. In addition, iridium is widely used in implantable stim-
ulating electrodes due to its biocompatibility [25]. Sputtering 
or electrodeposition of iridium oxide is a typical process used 
in the construction of neural electrical recording electrodes, 
such as the Utah microelectrode array [26]. Chemical sensing 
of dopamine has previously been achieved in vivo and suc-
cessfully integrated into closed-loop neurostimulating devices 
[27], but chemical sensing of the peripheral nervous system 
in vivo has not yet been achieved. Advances in chemical 
sensing technologies mean it is now possible that pHe record-
ings could be incorporated into closed-loop neurostimulating 
devices. However pHe changes in the vagus nerve have not yet 
been demonstrated in vivo.
In this paper, we aimed to determine (a) whether IrOx 
microelectrodes have sufficient pH sensitivity as to detect 
changes in pHe in the in vivo vagus nerve associated with nat-
urally occurring satiety signals, and (b) whether such changes 
in pHe could be used for closed-loop VNS.
2. Methods
2.1. Production of IrOx microelectrodes
Iridium wire (0.125 mm temper annealed) was soldered to the 
exposed end of a covered stainless steel wire. A heat shrink 
was applied to the exposed connection and Araldite glue 
applied to each end. After drying, iridium microelectrodes 
were oxidised in dilute sulphuric acid (0.5 M) using cyclic 
voltammetry (CHI760E electrochemical workstation, CH 
Instruments, USA) for 2.5 h.
2.2. Calibration of in-house constructed IrOx  
mircroelectrodes and Utah electrodes
IrOx microelectrodes and commercially available Utah array 
were tested for pH sensitivity using 5 pH buffers (pH4-8). 
Custom made Matlab code then determined the electrochem-
ical potential of each IrOx microelectrode and Utah array. For 
in vivo studies, only IrOx microelectrodes with a sensitivity 
of  >40 mV/pH were used.
2.3. Animals
Male Wistar rats (average weight 350 g, range 300–400 g) 
were used in all experiments and were obtained from Charles 
River. All experiments were conducted in accordance with 
the Animal (Scientific Procedures) Act 1986 and following 
local ethical approval. Unless otherwise stated, animals were 
allowed ad libitum access to food and water and were main-
tained on a 12 h light:dark cycle.
2.4. pH measurements from subdiaphragmatic vagus
Rats were initially anaesthetised with isoflurane. An intrave-
nous cannula was inserted into the tail vein, through which ure-
thane was slowly infused (20 mg kg−1) over a period of 25 min, 
during which isoflurane was slowly reduced to zero. Full anaes-
thesia was assessed through absence of forepaw pinch reflex. 
Throughout the procedure, body temperature was monitored 
via rectal thermistor and maintained at 37  ±  1 °C (PhysioSuite, 
Kent Scientific). Heart rate and oxygen saturation were moni-
tored through a pulse oximeter (PhysioSuite, Kent Scientific). 
Once fully anaesthetised, a midline incision was made in the 
neck and the trachea exposed, incised and intubated, to allow 
artificial ventilation (WPI, CW-SAR1000). To record pH 
changes in the subdiaphragmatic vagus nerve, a midline inci-
sion was made in the abdomen, the oesophagus and subdia-
phragmatic vagus nerve were exposed and a small thread placed 
under the vagus. The IrOx microelectrode was inserted into the 
vagus nerve and the abdominal cavity was filled with warmed 
paraffin oil. A silver-silver chloride (Ag/AgCl) electrode was 
placed inside the abdominal cavity to act as a reference.
2.5. Cervical stimulation and electrical recording
In a subset of animals (n  =  13), the ipsilateral vagus nerve was 
stimulated at the cervical level. The cervical vagus nerve was 
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exposed using the same midline incision used for ventilation, 
and a pseudo-tripolar electrode was placed under the nerve. 
A bipolar platinum electrode was placed inferior to the IrOx 
microelectrode for electrical recording of stimulated com-
pound action potentials (CAPs). Symmetric biphasic pulses 
of 0.1, 0.2, 0.5 and 1 ms, with currents ranging from 0 to 3 mA 
were applied to the cervical ipsilateral branch (Keithley 6221 
current source, Tektronix, USA), programmed via custom 
made Matlab script. Each current was iterated 10 times and 
averaged. Signals were then integrated over bins of 2 ms and a 
threshold applied (90th percentile of all signals) to detect clus-
ters of A and C fibre activity. C fibre threshold was set at 2 m s−1. 
These strength-duration curves were model led using Weiss’ 
equation: Rheobase * (1  +  Chronaxie⁄PW), where PW is the 
pulse width. In the control case, no electrode was inserted and 
four strength durations generated. CAPs were recorded using 
a RHD200 Series amplifier (Intan Technologies, USA) which 
utilises the multichannel RHD2132 Digital Electrophysiology 
Interface Chip (gain 45.66 dB, bandwidth 0.2–7.2 kHz). The 
signal was recorded using Intan’s data acquisition software. 
Bipolar platinum electrodes; similar to those used to record, 
were placed under the abdominal skin to act as reference 
electrodes.
2.6. CCK studies
In a subset of rats (n  =  6), CCK at increasing doses (50– 
300 pmol kg−1) was administered to stimulate the vagus 
nerve. The IrOx electrodes were tested prior to and after the 
experiment to determine their sensitivity. Following introduc-
tion of the IrOx microelectrode, animals were left to stabilise 
for 10–15 min. Following baseline pH measurements, CCK-8 
(Tocris Bioscience, UK) was dissolved in saline and the 
required amount drawn into a 250 µl Hamilton syringe, which 
was back filled with saline. CCK was delivered through the 
i.v. tail cannula, with a further 250 µl saline used to flush the 
cannula. A minimum of 15 min was left between subsequent 
injections.
2.7. Gastric distension
In a subset of animals (n  =  5), gastric inflation was used to 
stimulate afferent vagal nerve activity. Animals were fasted for 
24 h prior to the experiment. Following exposure of the vagus 
nerve, as detailed above (section 2.4), but prior to insertion of 
the IrOx microelectrode, an 8Fr Foley catheter with 3 ml balloon 
was inserted into the stomach through the oesophagus, with the 
balloon positioned inside the stomach. The IrOx microelectrode 
was then inserted into the vagus nerve and the animal was left to 
stabilise for 10–15 min. Following baseline pH recordings, the 
balloon was inflated for 3 min with increasing volumes of saline 
(0.5, 1, 2 and 3 ml), with a minimum of 15 min between inflations.
2.8. Data acquisition
pH data was collected from the sensors in vivo using com-
mercially available multichannel instrumentation amplifiers, 
EMF 6 (Lawson Labs Inc, USA), in differential configuration. 
The sampling rate of the data acquisition was set at 5 Hz per 
channel to capture pH changes and safely avoid high fre-
quency electromagnetic or line interference at 50 Hz. The data 
acquisition and amplifier configuration was performed using 
customised software provided by Lawson Labs.
2.9. Data analysis
The recorded neural pH signal typically consists of inherent 
drift originating from the open circuit potential of the IrOx 
electrode [28]. This linear drift was negative in almost all 
instances, and was unidirectional throughout the recording. 
As part of the post-experiment data analysis procedure, the 
acquired data was subjected to linear estimation using custom 
made Matlab script, to account for the linear electrode drift. 
This was done by selecting an observation window (OW), 
prior to the injection time. The size of the OW varied between 
2 and 5 min dependent on the variance of drift. The size of 
the OW was chosen from the instance when the stimulus was 
introduced to point of slope changes. After choosing a suitable 
OW size, a linear regression was applied on the pre-injection 
pH waveform. As shown in figure  1(A), the pH waveform, 
including pre-stimulus pH waveform and the observed pH 
change in response to the stimulus was subtracted, from the 
OW linear estimation to subtract background and remove 
Figure 1. (A) The linear estimation of the observation window 
(OW) is subtracted from the pH waveform to remove linear drift 
from electrodes. (B) Linear estimation of neural pH waveform in 
epochs of 1 min. Epoch (I) (purple line) shows the pre-injection 
linear estimation of the pH slope followed by a linear estimation 
of the fall in pH in epoch (II) (green line) which exhibits an 
approximate slope of  −0.03 pH units min−1, in response to  
300 pmol kg−1 CCK. The pH recovers in epoch (III) (second purple 
line) at a relatively slower rate.
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electrode drift to give an accurate value of the pH change 
associated to the stimulus.
To calculate relative pH change, baseline pH and peak pH 
values were obtained by recording the average value of a 5 s 
window just prior to the stimulus and at peak change. The 
relative pH change was then calculated by subtracting these 
values.
2.10. Statistical analysis
To determine whether relative changes in pH to a given stim-
ulus were statistically significant, paired t-tests were used to 
compare baseline against peak pH change. A p value of  <0.05 
was considered statistically significant. Values for each 
stimulus from each animal were then pooled and a one-way 
ANOVA was used to determine significance between groups.
2.11. Code calibration for closed-loop experiments
The data recorded by the EMF 6 was monitored in real time 
using a Matlab script and converted into pH values from 
voltage values based on the sensitivity of IrOx electrodes mea-
sured prior to the experiment. In order to detect the pH change 
due to CCK injection, the pH waveform was monitored for 
a period of 5 min pre-injection. This period is referred to as 
the code calibration period. During code calibration, a linear 
estimation was applied to the waveform over OW epochs of 
1 min to calculate linear drift/slope of the pH in the nerve. The 
reason for applying a linear estimation was to apply the trans-
formation between pH and voltage in accordance with the 
Nernst equation. At the end of the code calibration period, the 
mean slope and the slope standard deviation of 1 min epochs 
was recorded and CCK was injected. The above method was 
adopted to mitigate the effect of large non-linear changes in 
real time.
2.12. Detection of pH change for closed-loop stimulation
After code calibration (section 2.11) and CCK injection (sec-
tion 2.6), the pH waveform following injection was also mon-
itored in epochs of 1 min (figure 6(C)), in which the linear 
regression was applied on the epochs in real time. However, 
this time, the epoch slope was subtracted from the mean 
code calibration slope to minimise false detection. Previous 
experiments in which 300 pmol kg−1 CCK was applied (sec-
tion 3.3) showed that this dose of CCK produces a change in 
pH of  −0.03  ±  0.01 pH min−1 before returning to baseline. 
At any given time the code ensures that the epoch slopes of 
the past 2 min and the pH waveform are stored. If the ΔpH 
slope of the previous epoch is negative and its absolute value 
is 0.03  ±  0.01 pH min−1, the code then checks ΔpH slope in 
the subsequent epoch to be positive (i.e. returning to baseline). 
If this condition is satisfied, then the pH waveform trend is 
said to be similar to the CCK response trend (figure 6(C)). 
The stimulation parameters (frequency, pulse width of stimu-
lation, duration of stimulation and stimulation current) having 
been programmed into the Keithley 6221 current source using 
the Matlab script prior to injection, and on detection of the 
pH slope trend, the Keithely 6221 was signalled to start elec-
trical stimulation. With the above univariate methodology of 
CCK-pH response detection, there is a minimum delay of 
2 min between CCK injection and start of stimulation. At the 
onset of stimulation, the epoch slopes are not monitored for a 
period of 15 min before the next CCK injection.
3. Results
3.1. pH sensitivity of IrOx microelectrodes and Utah array
The pH sensitivity of in-house constructed IrOx microelec-
trodes was determined before and after each experiment. 
Because the Utah array is a validated electrode for clinical use 
[29, 30], the pH sensitivity of an iridium oxide constructed 
Utah array was also determined. Figure 2(A) shows the typ-
ical pH response slope of a single in-house constructed IrOx 
microelectrode compared to an IrOx constructed Utah array. 
This IrOx microelectrode shows a pH sensitivity of  −75.39  ± 
0.07 mV/pH unit. In comparison, the Utah array has a slightly 
lower pH sensitivity of  −59.9  ±  4.8 mV/pH unit. Figure 2(B) 
shows the average pH sensitivity of a population of IrOx 
microelectrodes before and after experimentation, demon-
strating a slight decrease in sensitivity after experimentation 
(−68.78  ±  5.3 mV/pH unit versus  −64.75  ±  7.94 mV/pH, 
p  <  0.002, n  =  16).
3.2. Nerve integrity testing
Strength duration curves were produced by electrical stimula-
tion of the ipsilateral vagus nerve at the cervical level before 
and after IrOx electrode insertion into the subdiaphragmatic 
region. Rheobase is a measure of neuronal excitability, and 
is defined as the minimum current required to depolarise a 
neuronal membrane. Chronaxie is the minimum time required 
for a current double the rheobase to depolarise a neuronal 









Where I relates to current, b rheobase, c chronaxie and d 
duration.
Rheobase and chronaxie measurements showed no 
significant alterations in excitation properties (figure 3). 
Furthermore, latency to activation, fibre type activation and 
stimulation threshold were unaltered. Control experiments, in 
which multiple strength duration stimulations were performed 
in the absence of IrOx electrode insertion showed no altera-
tions in nerve responses. This suggests that insertion of the 
IrOx electrodes into the subdiaphragmatic vagus nerve does 
not result in acute injury to the nerve.
3.3. CCK-induced changes in pHe
The ability of CCK to produce detectable changes in pHe in the 
subdiaphragmatic vagus nerve was investigated. Intravenous 
injection of increasing doses of CCK (50, 100, 300 and 
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1000 pmol kg−1) produced significant dose-dependent acidosis 
in the vagus nerve of 0.014  ±  0.004 pH units for 50 pmol kg−1 
to 0.039  ±  0.007 pH units for 1000 pmol kg−1 (figure 4). 
In some cases, this acidosis was followed by alkalosis 
(as observed in figure 6). The decrease in pH started within 
15 s of injection, and lasted between 3 and 4 min before 
returning to baseline. Injection of saline alone did not result in 
any significant change in pHe (figure 4(E)).
3.4. Gastric distension-induced changes in pHe
We then determined whether gastric distension produced 
detectible changes in pHe in the vagus nerve. Small disten-
sion volumes (0.5–1 ml) produced a reproducible alkalosis 
of 0.017  ±  0.0009 and 0.025  ±  0.003 pH units respectively 
(figures 5(A) and (B)). In 55% of cases, larger distension 
volumes (2–3 ml) produced an alkalosis of 0.05  ±  0.01 and 
0.03  ±  0.004 pH units respectively (figures 5(C) and (E)), 
whereas in the remaining 45% of animals, an acidosis was 
observed of magnitude 0.05  ±  0.01 pH units and 0.06  ±  0.01 
pH units for 2 and 3 ml respectively (figures 5(D) and (F)).
3.5. Demonstration of closed-loop capabilities of pHe  
measurements
Finally, we sought to demonstrate that IrOx-measured pHe 
changes in the subdiaphragmatic vagus nerve could be used 
for closed-loop VNS. Intravenous infusion of 300 pmol kg−1 
CCK produced a significant change in pHe (as described above 
in section 3.3). Matlab code produced in house automatically 
identified the shift in pH and triggered a neurostimulator 
implanted on the ipsilateral cervical vagus nerve (figures 6(A) 
and (B)). Automatic stimulation of the left vagus nerve was 
associated with a reduction in heart rate that lasted for the 
duration of stimulation, before returning to baseline. CCK 
injection itself was also associated with a modest decrease in 
heart rate, which has been described previously [31] and was 
less than that observed for VNS. Stimulation of the ipsilat-
eral vagus nerve also caused profound changes in pHe (likely 
due to stimulation-induced electrical activity). This lasted 
for around 10 min before returning to baseline. The detection 
algorithm is written as such that following positive detec-
tion of a CCK-induced pHe change; no further changes are 
recorded for 15 min. This mitigates the risk of false positive 
detections caused by stimulation-induced pHe changes.
4. Discussion
In this paper we demonstrate a method for recording changes 
in extracellular pH in the subdiaphragmatic vagus nerve in 
vivo, in the anaesthetised rat. Furthermore we provide evi-
dence that pHe can be incorporated into, and used for closed-
loop neurostimulation.
It has been previously documented in vitro that electrical 
activity of neurons is coupled with changes in extracellular pH 
[17, 18, 20]. Furthermore, IrOx has previously been validated 
as a pH sensor [22, 32], however IrOx microelectrodes have 
never before being applied to the measurement of pH fluxes 
in peripheral nerves. This has traditionally been achieved 
through the use of glass micropipettes in ex vivo nerve prep-
arations. Due to technical limitations, the use of such micro-
pipettes in vivo is challenging, and due to their fragility and 
Figure 2. (A) Representative calibration curve for in-house 
constructed iridium oxide microelectrodes (circles) and 
commercially available Utah array (triangles). Immersion of 
electrodes in buffers of increasing pH results in a decrease in 
evoked voltage potential. This individual in-house iridium oxide 
electrode shows a pH sensitivity of  −75.39  ±  0.77 mV/pH unit, 
whereas the Utah array shows a slightly lower pH sensitivity 
of  −59.9  ±  4.8 mV/pH unit. (B) Change in sensitivity of in-house 
constructed IrOx microelectrodes before and after experimentation. 
Electrodes were calibrated before and after each experiment. 
After removal from the animal, electrodes show a small but 
significant decrease in sensitivity (before  =  68.78  ±  5.306, 
After  =  64.75  ±  7.94, n  =  16). (C) Comparison between in-
house constructed IrOx microelectrodes (left) with commercially 
available Utah array (right). 5 pence is added for scale (5p  =  18 mm 
diameter). **  =  p  <  0.002. Bars show mean  ±  SD.
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inability to be miniaturised, such micropipettes are unsuitable 
for implantation. Here, we have demonstrated that IrOx micro-
electrodes are sufficiently sensitive to measure changes in pHe 
in neuronal tissue in vivo caused by physiological stimuli and 
such changes can be used to drive algorithms for closed-loop 
neuromodulation.
The vagus nerve is a highly complex nerve, receiving sen-
sory information from both thoracic and abdominal organs. In 
this regard, signals arising from the gastrointestinal tract can 
be masked by afferent information arising from cardiorespi-
ratory organs. In order to overcome this issue, we recorded 
pHe changes specifically from the subdiaphragmatic region 
of the vagus nerve, which does not receive afferent informa-
tion from such organs. Furthermore, as this was a proof-of-
concept study, animals were artificially ventilated throughout 
the experiment in order to prevent any changes in spontaneous 
ventilation which could result in changes in systemic pH. 
Nevertheless, given the homeostatic mechanisms involved 
in regulating systemic pH in the conscious animal, we do 
not anticipate such changes to significantly affect recording 
accuracy.
Following CCK administration, pHe reliably and reproduc-
ibly became more acidic, regardless of the administered dose. 
This contrasts with gastric distension, whereby small levels 
of distension (0.5–1 ml) produced alkaline responses, but 
larger levels of distension (2–3 ml) either produced a biphasic 
alkaline followed by acidic response, or acidic only. The 
reasons for this difference in response to the same stimulus 
across animals are not fully understood, nor are the under-
lying mechanisms governing pHe changes associated with 
neural activity. However, both acidic, alkaline and biphasic 
changes in pHe have been observed by others [33–36]. Kraig 
et  al found that repetitive stimulation of the rat cerebellum 
often, but not always, resulted in an initial alkaline shift 
[33]. This initial alkaline shift was blocked by Mn2+, a cal-
cium channel blocker, suggesting a role for calcium-induced 
neuronal activity. In contrast, Chesler and Chen found that 
stimulation of the turtle cortex in vitro resulted in alkalisa-
tion, which lasted for the duration of the stimulus and was also 
blocked by application of Mn2+ [36]. The vagus nerve has 
previously been shown to respond with a brief alkalisation fol-
lowed by acidification following stimulation in vitro, although 
no underlying mechanism was investigated [18], however, it 
has previously been suggested that acidosis could be the result 
of metabolic acidosis [37]. In our study, we have observed 
both acidic and alkaline changes in pHe in the vagus nerve in 
response to two distinct physiological stimuli. In the case of 
gastric distension, we observed both alkaline shifts and acidic 
shifts to the same level of stimulus across animals. If the acidi-
fication is due to metabolic acidosis, this may represent differ-
ences in the ability of the nerve to respond to large stimuli, or 
may be related to differences in the interaction with afferent 
fibres communicating gastric distension in the nerve, since 
these contribute only a minor population [8]. In this paper, 
we have not sought to add information as to the mechanisms 
by which pHe changes occur in response to neural activity, 
but have sought to demonstrate the applicability of pHe to 
closed-loop neurostimulation. In this demonstration, we used 
300 pmol kg−1 CCK as the stimulus, which produces repro-
ducible changes in pHe, with a characteristic shape, slope and 
peak pHe change across animals. Through this, the detec-
tion algorithm could be ‘trained’ to detect this characteristic 
change in pHe, thus reducing the chances of false-positive 
detections. The different responses in pHe associated with 
gastric distension produce an obvious limitation to the algo-
rithm design, however provided the response is maintained in 
Figure 3. Electrical stimulation of the ipsilateral vagus nerve before and after (a) IrOx electrode insertion, or without electrode insertion 
(b). No significant changes were observed in either rheobase or chronaxie measurements following IrOx insertion or following repeated 
stimulation, suggesting acute IrOx insertion does not result in significant nerve damage.
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each individual animal, it is possible that the algorithm could 
be trained in the same manner.
The electrochemical potential of iridium oxide in a solu-
tion depends mainly on the pH of the media, since an electro-
chemical equilibrium between the iridium oxide and the H+ 
ions is established as described by the following equation:
2IrO2 + 2H+ + 2e− ↔ Ir2O3 + H2O.
This equilibrium is governed by the Nerst equation:
E = E0 +
RT
nF
log10(CH) = E0 − 0.059 pH.
This equation  predicts that the electrochemical potential of 
the iridium oxide electrodes changes linearly with the pH 
with a typical slope of  −59 mV/pH unit. In reality, interfa-
cial equilibrium is slightly more complex which accounts for 
larger slopes, typically ranging from  −59 to  −90 mV/pH unit 
depending on the preparation protocols. Using our protocols, 
we demonstrate a pH sensitivity of  −68.78  ±  5.3 mV/pH unit. 
The differences between measured and theoretical pH sensi-
tivities of IrOx are dependent upon the reduction state of the 
anodic iridium oxide film, with the reduced state having more 
acidic properties than the oxidised form [38] and are therefore 
influenced by oxidising paradigm and efficiency.
Recording neural activity has become a major challenge in 
the expanding field of neuro-technology. Electrical recording 
from within neural tissue offers significantly enhanced spa-
tiotemporal resolution when compared to non-invasive tech-
niques (e.g. fMRI, EEG) [39]. However recordings from 
peripheral nerves are especially associated with interference 
from neighbouring electrically dependent processes (e.g. heart 
rate, respiration, muscle movement) [40]. Small electrical sig-
nals produced by peripheral nerves, as well as the presence of 
interfering bioelectrical signals from distal tissues within the 
bandwidth of interest, produce challenges for electronic front-
ends and interfaces [41]. We sought to overcome these limi-
tations by recording chemical changes associated with nerve 
activity. Chemical signals have significantly higher amplitude 
(tens of millivolts) and hence better SNR compared with tra-
ditional electrical recordings. The chemical signals also have 
lower bandwidth, hence making them easy to separate from 
interferences such as cardiorespiratory signals. In the con-
text of the vagus nerve, we have demonstrated that chemical 
neural recordings can be used as a viable means of detecting 
Figure 4. (A)–(E) Saline and CCK-induced changes in pHe in the subdiaphragmatic vagus nerve with intravenous administration of 
increasing doses of CCK (50–1000 pmol kg−1, n  =  6 animals). (F) Average peak changes in pHe in response to increasing doses of CCK. 
One-way ANOVA revealed significant changes in pHe in all doses against equi-volume administration of saline alone. *  =  p  <  0.05, 
**  =  p  <  0.001, ****  =  p  <  0.0001 versus saline.
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changes in neural activity as a result of physiological events. 
We have also demonstrated that neural pHe changes observed 
in relation to CCK and gastric distension have characteristic 
shapes and follow dose-response relationships.
In order to further increase spatial resolution of neural 
recordings, various laboratories have developed high density 
multielectrode arrays (MEAs), with large numbers of indi-
vidually addressable spikes. Many of these MEAs have the 
added benefit of varying spike length, offering further spatial 
resolution. One such device is the commercially available 
Utah electrode array (UEA), which is constructed from either 
platinum or iridium oxide. Because of its construction from 
IrOx, and its previous use in clinical applications [29, 30], 
we further provided evidence that the UEA has pH sensing 
capabilities. The development of a slanted UEA for use in 
peripheral nerves [26], further increases the possibility that 
devices such as the UEA can be used for human pHe nerve 
recordings.
Figure 5. Distension-induced changes in pHe in the subdiaphragmatic vagus nerve ((A)–(D), 0.5–3 ml). Small levels of distension (A) and 
(B) produce an alkaline shift in pHe. Higher levels of distension produce both biphasic (C), acidotic (D) and (F) and alkaline (E) shifts in 
pH. (G) Average peak change in pHe for each level of distension (*  =  p  <  0.05, **  =  p  <  0.01, n  =  5 animals). Lines denote duration of 
distension.
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5. Conclusions
VNS has been shown to produce moderate effects on weight 
loss using current ‘open-loop’ technologies [2, 5, 42]. The 
addition of physiological feedback to create closed-loop VNS 
devices has been shown to offer greater efficacy [43, 44]. We 
provide a novel approach to providing physiological feedback 
to VNS devices, through the use of extracellular pH changes 
associated with neural activity. Furthermore, the use of pHe 
for the control of neural implants extends further than periph-
eral nervous tissues, and has the potential to integrate into 
central brain structures. The characteristic shape of neural 
pH change, its proportionality to dosage, ease of separation 
from interfering signals, the possibility to record neural pHe 
using IrOx, (which is a biocompatible material and has an 
established fabrication procedure), and the demonstration that 
pHe can be used in a closed-loop paradigm, demonstrates that 
chemical neural recording has the potential of being used as a 
viable neurotechnology within closed-loop implants.
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